Molecular and histopathologic predictors of distant failure in endometrial cancer
Cancer Detection and Prevention · 2003
DOI: 10.1016/j.cdp.2003.09.005 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Cancer Detection and Prevention, 2003. Verfasst von Andrea Mariani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Mariani, A., Sebo, T. J., Webb, M. J., Riehle, D., Katzmann, J. A., Keeney, G. L., Roche, P. C., Lesnick, T. G., & Podratz, K. C. (2003). Molecular and histopathologic predictors of distant failure in endometrial cancer. Cancer Detection and Prevention. https://doi.org/10.1016/j.cdp.2003.09.005
Vancouver
Mariani A, Sebo TJ, Webb MJ, Riehle D, Katzmann JA, Keeney GL, et al. Molecular and histopathologic predictors of distant failure in endometrial cancer. Cancer Detection and Prevention. 2003. doi:10.1016/j.cdp.2003.09.005
BibTeX
@article{Mariani2003,
author = {Mariani, Andrea and Sebo, Thomas J and Webb, Maurice J and Riehle, Darren and Katzmann, Jerry A and Keeney, Gary L and Roche, Patrick C and Lesnick, Timothy G and Podratz, Karl C},
title = {Molecular and histopathologic predictors of distant failure in endometrial cancer},
journal = {Cancer Detection and Prevention},
year = {2003},
doi = {10.1016/j.cdp.2003.09.005}
}
EUVIMED